
- 2 out of 5 adults suffer from heartburn at least once a month
- As many as 10% of GERD patients develop Barrett's esophagus (pre-cancerous condition of the esophagus)
|
WELCOME TO TORAX MEDICAL
Torax Medical was founded in 2002 with the mission of creating a better treatment option for patients suffering from Gastroesophageal Reflux Disease (GERD).
Through these efforts, Torax has pioneered a new technology platform called Magnetic Sphincter Augmentation (MSA) which may be applied to a variety of conditions throughout the body.
The LINX™ Reflux Management System for the treatment of GERD is currently under clinical investigation; active research is ongoing in other fields of use.
Torax Medical is a privately held corporation that is based in the
Minneapolis/St.Paul area.